{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:36:22Z","timestamp":1790260582032,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":2406,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1124\/jpet.118.248575","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T14:15:49Z","timestamp":1524147349000},"page":"676-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Potent Sodium\/Glucose Cotransporter SGLT1\/2 Dual Inhibition Improves Glycemic Control Without Marked Gastrointestinal Adaptation or Colonic Microbiota Changes in Rodents"],"prefix":"10.1016","volume":"365","author":[{"given":"Fuyong","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Hinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandre","family":"Cavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Polidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanial","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Jennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee-Hong","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal D.","family":"Gaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Lenhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Demarest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim J.","family":"Ajami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Hornby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.248575_bib1","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.2337\/db13-0604","article-title":"Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30-50% of filtered glucose load in humans","volume":"62","author":"Abdul-Ghani","year":"2013","journal-title":"Diabetes"},{"key":"10.1124\/jpet.118.248575_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJM198104093041507","article-title":"Incomplete absorption of the carbohydrate in all-purpose wheat flour","volume":"304","author":"Anderson","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.118.248575_bib3","doi-asserted-by":"crossref","first-page":"C475","DOI":"10.1152\/ajpcell.00180.2008","article-title":"Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody","volume":"295","author":"Balen","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/jpet.118.248575_bib4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0016-5085(80)90854-9","article-title":"Colonic conservation of malabsorbed carbohydrate","volume":"78","author":"Bond","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.118.248575_bib5","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/ismej.2012.8","article-title":"Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms","volume":"6","author":"Caporaso","year":"2012","journal-title":"ISME J"},{"issue":"Suppl 1","key":"10.1124\/jpet.118.248575_bib6","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1073\/pnas.1000080107","article-title":"Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample","volume":"108","author":"Caporaso","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.118.248575_bib7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.gastro.2015.10.009","article-title":"Differences in alimentary glucose absorption and intestinal disposal of blood glucose after Roux-en-Y gastric bypass vs sleeve gastrectomy","volume":"150","author":"Cavin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.118.248575_bib8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI100559","article-title":"The action of phlorizin on the excretion of glucose, xylose, sucrose, creatinine and urea by man","volume":"12","author":"Chasis","year":"1933","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.118.248575_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13300-010-0006-4","article-title":"Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members","volume":"1","author":"Chen","year":"2010","journal-title":"Diabetes Ther"},{"key":"10.1124\/jpet.118.248575_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2014.09.018","article-title":"Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin","volume":"224","author":"De Jonghe","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1124\/jpet.118.248575_bib11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40262-015-0285-z","article-title":"Clinical pharmacokinetic, pharmacodynamic, and drug-drug interaction profile of canagliflozin, a sodium-glucose co-transporter 2 inhibitor","volume":"54","author":"Devineni","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.118.248575_bib12","doi-asserted-by":"crossref","first-page":"G946","DOI":"10.1152\/ajpgi.00286.2014","article-title":"Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release","volume":"308","author":"Dobbins","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.118.248575_bib13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s11605-008-0776-4","article-title":"Hexose transporter expression and function in mouse small intestine: role of diurnal rhythm","volume":"13","author":"Fatima","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"10.1124\/jpet.118.248575_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/014860719301700147","article-title":"Glutamine enhancement of structure and function in transplanted small intestine in the rat","volume":"17","author":"Frankel","year":"1993","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1124\/jpet.118.248575_bib15","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s001250051092","article-title":"Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima fatty rats","volume":"41","author":"Fujita","year":"1998","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.118.248575_bib16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.bmc.2012.11.041","article-title":"Design, synthesis, and structure-activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl \u03b2-D-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)","volume":"21","author":"Fushimi","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.118.248575_bib17","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMoa1708337","article-title":"Effects of sotagliflozin added to insulin in patients with type 1 diabetes","volume":"377","author":"Garg","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.118.248575_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/db11-1029","article-title":"Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion","volume":"61","author":"Gorboulev","year":"2012","journal-title":"Diabetes"},{"key":"10.1124\/jpet.118.248575_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1005477204960","article-title":"Role of Na+-glucose cotransport in jejunal meal-induced absorption","volume":"45","author":"Hines","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.118.248575_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2017.08.031","article-title":"Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet","volume":"492","author":"Hira","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.118.248575_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nut.2008.07.006","article-title":"Inductions of histone H3 acetylation at lysine 9 on SGLT1 gene and its expression by feeding mice a high carbohydrate\/fat ratio diet","volume":"25","author":"Honma","year":"2009","journal-title":"Nutrition"},{"key":"10.1124\/jpet.118.248575_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2017.04.010","article-title":"Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation","volume":"806","author":"Inoue","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.248575_bib23","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bmcl.2018.02.057","article-title":"Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1\/SGLT2 dual inhibitors","volume":"28","author":"Kuo","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.118.248575_bib24","series-title":"Optimization in Drug Discovery: Methods in Pharmacology and Toxicology","first-page":"461","article-title":"Drug, lipid, and acylcarnitine profiling using dried blood spot (DBS) technology in drug discovery","author":"Lang","year":"2014"},{"key":"10.1124\/jpet.118.248575_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1479164114563304","article-title":"Development of sotagliflozin, a dual sodium-dependent glucose transporter 1\/2 inhibitor","volume":"12","author":"Lapuerta","year":"2015","journal-title":"Diab Vasc Dis Res"},{"key":"10.1124\/jpet.118.248575_bib25","doi-asserted-by":"crossref","first-page":"G887","DOI":"10.1152\/ajpgi.00068.2016","article-title":"Intestinal SGLT1 in metabolic health and disease","volume":"310","author":"Lehmann","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.118.248575_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/bj2950211","article-title":"Differential responses of intestinal glucose transporter mRNA transcripts to levels of dietary sugars","volume":"295","author":"Miyamoto","year":"1993","journal-title":"Biochem J"},{"key":"10.1124\/jpet.118.248575_bib27","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.2337\/dc15-0642","article-title":"Sodium-glucose cotransporter inhibitors: effects on renal and intestinal glucose transport: from bench to bedside","volume":"38","author":"Mudaliar","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1124\/jpet.118.248575_bib28","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1210\/jc.2014-3144","article-title":"Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemia","volume":"100","author":"Nguyen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.118.248575_bib29","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/dom.13003","article-title":"Sodium-glucose co-transporter (SGLT) and glucose transporter (GLUT) expression in the kidney of type 2 diabetic subjects","volume":"19","author":"Norton","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/jpet.118.248575_bib30","doi-asserted-by":"crossref","first-page":"G851","DOI":"10.1152\/ajpgi.2000.279.5.G851","article-title":"Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells","volume":"279","author":"Nusrat","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.118.248575_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jphs.2016.10.006","article-title":"Changes in glucose-induced plasma active glucagon-like peptide-1 levels by co-administration of sodium-glucose cotransporter inhibitors with dipeptidyl peptidase-4 inhibitors in rodents","volume":"132","author":"Oguma","year":"2016","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.118.248575_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02209145","article-title":"Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat","volume":"100","author":"Pappenheimer","year":"1987","journal-title":"J Membr Biol"},{"key":"10.1124\/jpet.118.248575_bib33","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00125-012-2585-2","article-title":"Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion","volume":"55","author":"Parker","year":"2012","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.118.248575_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MPG.0000000000000114","article-title":"Bitterness of glucose\/galactose: novel mutations in the SLC5A1 gene","volume":"58","author":"Pode-Shakked","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1124\/jpet.118.248575_bib35","doi-asserted-by":"crossref","first-page":"E867","DOI":"10.1210\/jc.2012-4205","article-title":"Validation of a novel method for determining the renal threshold for glucose excretion in untreated and canagliflozin-treated subjects with type 2 diabetes mellitus","volume":"98","author":"Polidori","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.118.248575_bib36","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.2337\/dc12-2391","article-title":"Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study","volume":"36","author":"Polidori","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1124\/jpet.118.248575_bib37","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.1152\/ajpendo.00439.2012","article-title":"Improved glycemic control in mice lacking Sglt1 and Sglt2","volume":"304","author":"Powell","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.118.248575_bib38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1124\/jpet.114.214304","article-title":"Effect of LX4211 on glucose homeostasis and body composition in preclinical models","volume":"350","author":"Powell","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248575_bib39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/jpet.113.203364","article-title":"LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium\/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose","volume":"345","author":"Powell","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248575_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/jpet.117.240820","article-title":"LX2761, a sodium\/glucose cotransporter 1 inhibitor restricted to the intestine, improves glycemic control in mice","volume":"362","author":"Powell","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248575_bib41","doi-asserted-by":"crossref","first-page":"e89977","DOI":"10.1371\/journal.pone.0089977","article-title":"The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing","volume":"9","author":"R\u00f6der","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.118.248575_bib42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1463-1326.2011.01406.x","article-title":"Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects","volume":"13","author":"Sha","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/jpet.118.248575_bib43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/jpet.112.193045","article-title":"KGA-2727, a novel selective inhibitor of a high-affinity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efficacy in rodent models","volume":"342","author":"Shibazaki","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248575_bib44","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/14728222.2016.1168808","article-title":"Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus","volume":"20","author":"Song","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"10.1124\/jpet.118.248575_bib45","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0016-5085(83)90012-4","article-title":"Passage of carbohydrate into the colon. Direct measurements in humans","volume":"85","author":"Stephen","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.118.248575_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00431-012-1802-9","article-title":"Congenital glucose-galactose malabsorption: a novel deletion within the SLC5A1 gene","volume":"172","author":"Vallaeys","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1124\/jpet.118.248575_bib47","first-page":"257","article-title":"Structure and function of the Na+\/glucose cotransporter","volume":"643","author":"Wright","year":"1998","journal-title":"Acta Physiol Scand Suppl"},{"key":"10.1124\/jpet.118.248575_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00418-011-0779-1","article-title":"Comparative expression of hexose transporters (SGLT1, GLUT1, GLUT2 and GLUT5) throughout the mouse gastrointestinal tract","volume":"135","author":"Yoshikawa","year":"2011","journal-title":"Histochem Cell Biol"},{"key":"10.1124\/jpet.118.248575_bib49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clinthera.2013.01.010","article-title":"Effects of LX4211, a dual SGLT1\/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes","volume":"35","author":"Zambrowicz","year":"2013","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.118.248575_bib50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/clpt.2012.58","article-title":"LX4211, a dual SGLT1\/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial","volume":"92","author":"Zambrowicz","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.118.248575_bib51","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.clinthera.2013.06.011","article-title":"Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects","volume":"35","author":"Zambrowicz","year":"2013","journal-title":"Clin Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524267963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524267963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.248575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:05:07Z","timestamp":1739977507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524267963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0022356524267963"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.248575","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733082820.793545979","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent Sodium\/Glucose Cotransporter SGLT1\/2 Dual Inhibition Improves Glycemic Control Without Marked Gastrointestinal Adaptation or Colonic Microbiota Changes in Rodents","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.248575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}